CandlesenseCandlesense
KTTAClinical Trials•globenewswire•

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sentiment:Negative (30)

Summary

Pasithea Tx (Nasdaq: KTTA) to present PAS-004 clinical progress at H.C. Wainwright Global Investment Conference on Sept. 10, 2025 in NYC.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 28, 2025 by globenewswire

← Back to KTTA News
    Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference | KTTA Stock News | Candlesense